{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:38:42Z","timestamp":1788385122401,"version":"build-2803163510"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Primary cutaneous follicle center lymphoma (PCFCL) is a rare form of indolent B-cell lymphoma limited to the skin. This study aims to explore various factors affecting overall survival in patients with PCFCL using data from the National Cancer Database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with PCFCL were identified in the National Cancer Database between 2004 and 2020 using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) histology code 9597. Time-to-event outcomes were analyzed with the Kaplan-Meier method, log-rank tests, and multivariable Cox hazard regression models to understand the association of demographic and prognostic factors on survival in patients with PCFCL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the study interval, 1293 patients were identified with PCFCL, of which 64% were male, 50% were Stage I, and 84% had a Charlson-Deyo (CD) comorbidity score of 0. Key factors associated with worse overall survival included lower income (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.030), nonprivate insurance (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and lower education levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015). Additionally, female sex (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.014), older age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), higher CD scores (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), stage II (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.013), stage III (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003), and lack of primary radiation therapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.047) were associated with lower survival. Multivariate analysis confirmed that elevated comorbidity index [hazard ratio (HR) = 5.96, 95% confidence interval (CI): 2.82\u201312.59,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001], older age (HR = 1.57, 95% CI: 1.41\u20131.74,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and higher disease stage (Stage I vs II: HR = 2.15, 95% CI: 1.07\u20134.29,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.031) were significantly associated with lower survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with PCFCL, female sex, older age, higher comorbidity index, higher disease stage, lower income, nonprivate insurance, and lower education levels were associated with lower overall survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sap.0000000000004434","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:00:08Z","timestamp":1754517608000},"page":"e64-e70","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Primary Cutaneous Follicle Center Lymphoma"],"prefix":"10.1097","volume":"95","author":[{"given":"Catherine S.","family":"Taghizadeh","sequence":"first","affiliation":[{"name":"Creighton University School of Medicine, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gejla","family":"Toromani","sequence":"additional","affiliation":[{"name":"Miami University, Oxford, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6403-502X","authenticated-orcid":false,"given":"Beau","family":"Hsia","sequence":"additional","affiliation":[{"name":"Creighton University School of Medicine, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rafie","sequence":"additional","affiliation":[{"name":"Arizona State University, Tempe, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Barrera","sequence":"additional","affiliation":[{"name":"Grand Canyon University, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Kalmar","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Department of Plastic Surgery, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"bib1-20251024","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"Who-EORTC classification for cutaneous lymphomas","volume":"105","year":"2005","journal-title":"Blood"},{"key":"bib2-20251024","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","year":"2019","journal-title":"Blood"},{"key":"bib3-20251024","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fonc.2020.00651","article-title":"Primary cutaneous B-cell lymphomas: an update","volume":"10","year":"2020","journal-title":"Front Oncol"},{"key":"bib4-20251024","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/10428190109097708","article-title":"Primary cutaneous follicle center cell lymphoma","volume":"42","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"bib5-20251024","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"key":"bib6-20251024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21037\/tlcr.2019.12.28","article-title":"Prognostic factors of lung cancer in lymphoma survivors (The Lucilys Study)","volume":"9","year":"2020","journal-title":"Translational Lung Cancer Research"},{"key":"bib7-20251024","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 who classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","year":"2011","journal-title":"Blood"},{"key":"bib8-20251024","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/cancers12061497","article-title":"Diagnosis and treatment of primary cutaneous B-cell lymphomas: state of the art and perspectives","volume":"12","year":"2020","journal-title":"Cancer"},{"key":"bib9-20251024","first-page":"21","article-title":"Immunophenotypic diagnosis of primary cutaneous lymphomas: a review for the practicing dermatologist","volume":"3","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"bib10-20251024","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new who\u2013EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","year":"2007","journal-title":"J Clin Oncol"},{"key":"bib11-20251024","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bjd\/ljae039","article-title":"Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study","volume":"190","year":"2024","journal-title":"Br J Dermatol"},{"key":"bib12-20251024","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"key":"bib13-20251024","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib14-20251024","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2217\/fon-2015-0028","article-title":"A brighter future? The impact of insurance and socioeconomic status on cancer outcomes in the USA: a review","volume":"12","year":"2016","journal-title":"Future Oncol"},{"key":"bib15-20251024","first-page":"542","article-title":"Health insurance status and cancer stage at diagnosis and survival in the United States","volume":"72","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"bib16-20251024","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ejca.2010.11.014","article-title":"Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a National Clinical Database","volume":"47","year":"2011","journal-title":"Eur J Cancer"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:00:51Z","timestamp":1761307251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004434"}},"subtitle":["Demographic, Socioeconomic, and Clinical Prognostic Factors in a National Cohort"],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000004434","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"2025-04-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}